Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00613041
Other study ID # 03-039
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 2003
Est. completion date November 3, 2021

Study information

Verified date September 2023
Source Memorial Sloan Kettering Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In recent years, more and more people are having lung CT scans performed to screen for various cancers. Many of them have small abnormalities detected, called "nodules", which - for a variety of reasons - doctors are unable to biopsy. As a result, many patients have their CT scans repeated on a regular basis to see if their nodules grow. This process can last several years. Many patients experience significant anxiety during this process, when they are aware of a spot in the lung, but are not told any specific cause. Researchers at Memorial Sloan-Kettering have developed a new way to look at lung nodules in three dimensions. The purpose of this project is to see if any change in the nodules can be detected sooner by this method than by traditional CT scans.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date November 3, 2021
Est. primary completion date November 3, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Referral to the pulmonary or thoracic surgery service for undiagnosed pulmonary nodules. - History of smoking exceeding 10 pack-years (pack year defined as number of packs of cigarettes per day multiplied by the number of years smoked). - Age >18 - Nodule size 5 to 15 mm in diameter. Exclusion Criteria: - Clinical indication for immediate biopsy via bronchoscopy, fine needle aspiration, or video-assisted thoracoscopic Surgery (VATS) - Active lung cancer or metastasis to the lung. - Contraindication to needle biopsy. - Pneumonectomy - Need for supplemental oxygen. - Radiation pneumonitis - Interstitial lung disease.

Study Design


Intervention

Procedure:
CT Scan
All patients will undergo serial CT scans after 3 months, 6 months, 9 months, 12 months, 18 months, and 24 months as is standard care. Nodules are to be scanned at 2.5mm collimation / 1.25 mm reconstruction. This resolution is necessary for volume measurements of nodules less than 1cm in diameter.

Locations

Country Name City State
United States Memorial Sloan Kettering Cancer Center New York New York

Sponsors (1)

Lead Sponsor Collaborator
Memorial Sloan Kettering Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To collect preliminary data regarding the comparative sensitivity and specificity of conventional CT scan and three-dimensional CT for detecting the growth of nonspecific pulmonary nodules. conclusion of the study
Secondary To determine three-dimensional characteristics of pulmonary nodules which may discriminate between benign and malignant diseases. conclusion of the study
See also
  Status Clinical Trial Phase
Recruiting NCT03339479 - Dielectric Property Test Compared With Frozen Pathological Section in the Rapid Diagnosis of Lung Nodules/Mass N/A
Recruiting NCT03992833 - Methods of Computed Tomography Screening and Management of Lung Cancer N/A
Recruiting NCT05994898 - Ultrahigh-frequency Ultrasonography (UHFUS) in Detection of Small Pulmonary Ground Glass Opacity (GGO)
Completed NCT02196974 - Bronchoscopic Approach to the Peripheral Lung Nodule - Endobronchial Ultrasound, Electromagnetic Navigation and Cryobiopsy N/A
Completed NCT00188409 - Pneumothorax Post CT Lung Biopsy N/A
Not yet recruiting NCT05511090 - Prospective Study to Observe and Manage Progression of Pulmonary Nodules